ALVO
ALVO
NASDAQ · Biotechnology

Alvotech Sa

$3.26
+0.06 (+1.88%)
As of May 9, 1:34 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 2 17%
Sell 1 8%
Price Target
Analyst Price Target +873.0% upside
Low Target $22.31
Average Target $31.72
High Target $46.94
Current Price $3.26
Current
$3.26
Target
$31.72
$22.31 $31.72 avg $46.94
Scenario Analysis
Bear Case
$22.31
584.4%
Low target
Base Case
$31.72
+873.0%
Avg target
Bull Case
$46.94
+1,339.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$11.85
-72.5% from high
52-Week Low
$3.03
+7.6% from low
Target vs 52W High
$31.72
+167.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%